Mitesh

Update: 11 July 2025 DHSC have provided an update that Bumetanide 1mg tablets are in limited supply until late July 2025 National Patient Safety Alert: Shortage Of Bumetanide 1mg Tablets National Patient Safety Alert Reference Number: NatPSA/2025/003/DHSC Date issued: 03 July 2025 Explanation of identified safety issue Bumetanide 1mg tablets are out of stock until [...]

The post National Patient Safety Alert: Shortage Of Bumetanide 1mg Tablets – Updated appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) Drug Alert Number: EL(25)A/31 Date issued: 30 June 2025 Wockhardt UK Limited is recalling the above batch as a precautionary measure following the identification of a dissolution failure during stability testing. DMRC reference number:DMRC-35980389 Marketing Authorisation Holder:Wockhardt UK Ltd Medicine Details Product name: Tamoxifen 20mg [...]

The post MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video introducing the Pricing Audit Team (PAT). The Pricing Audit Team undertake monthly audit checks to verify the accuracy of NHS pricing across prescriptions and the Margin Survey. For prescription pricing, pharmacy accounts are audited [...]

The post Funding & Reimbursement Shorts: Introduction to Pricing Audit Team appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (26/06/2025) confirmed the following list of price concessions for June 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £75.25 Alendronic acid 70mg tablets 4 £0.99 Buprenorphine 2mg sublingual tablets sugar free 7 £1.48 Buprenorphine 8mg sublingual tablets sugar free 7 £4.59 Carbocisteine 375mg capsules [...]

The post June 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 23rd June 2025, SSP083, provides that for every Venlafaxine 37.5mg modified-release tablet originally prescribed one Venlafaxine 37.5mg modified-release capsule must be supplied. SSP083, [...]

The post SSP for Venlafaxine 37.5mg modified-release tablets issued appeared first on Community Pharmacy England.